NURS 6512 Week 3 health assessment assignment
NURS 6512 Week 3. For this Assignment, you will consider the validity and reliability of different assessment tools and diagnostic tests. You will explore issues such as sensitivity, specificity, and positive and negative predictive values. You will also consider examples of children with various weight issues. You will explore how you could effectively gather information and encourage parents and caregivers to be proactive about their children’s health and weight.
To Prepare
Review this week’s Learning Resources and consider factors that impact the validity and reliability of various assessment tools and diagnostic tests. You also will review examples of pediatric patients and their families as it relates to BMI.
By Day 1 of this week, you will be assigned to one of the following Assignment options by your Instructor: Adult Assessment Tools or Diagnostic Tests (option 1), or Child Health Case (Option 2). This has been modified to make sense for you. THIS MAY NOT BE WHAT IT READS CURRENTLY UNDER WEEK 3 REQUIREMENTS.
Based on the Assignment option assigned to you, your Instructor will also assign you assessment tools or diagnostic tests to apply to either an adult or the child health example assigned to you.
Search the Walden Library and credible sources for resources explaining the tool or test you were assigned. What is its purpose, how is it conducted, and what information does it gather?
Also, as you search the Walden library and credible sources, consider what the literature discusses regarding the validity, reliability, sensitivity, specificity, predictive values, ethical dilemmas, and controversies related to the test or tool.
If you are assigned Assignment Option 2 (Child), consider what health issues and risks may be relevant to the child in the health example.
Based on the risks you identified, consider what further information you would need to gain a full understanding of the child’s health. Think about how you could gather this information in a sensitive fashion.
Consider how you could encourage parents or caregivers to be proactive toward the child’s health.
The Assignment
Last names A-M Assignment Option 1: Adult Assessment Tools/Diagnostic Tests (Choose one of the cases listed below)
Assignment (3–4 pages, not including title and reference pages):
Assignment Option 1: Adult Assessment Tools or Diagnostic Tests:
Assessment Tool/Diagnostic tool : PSA
Diagnostic Tool: Mammogram
Diagnostic Tool: PapSmear
Include the following:
A description of how the assessment tool or diagnostic test you were assigned is used in healthcare.
What is its purpose?
How is it conducted?
What information does it gather?
Based on your research, evaluate the test or the tool’s validity and reliability, and explain any issues with sensitivity, reliability, and predictive values. Include references in appropriate APA formatting.NURS 6512 Week 3
NURS 6512 Week 3 Answer
Diagnostic tools and tests are essential components of patient care delivery, aiding in the identification of medical conditions and the development of effective treatment plans. Healthcare professionals must possess comprehensive knowledge of the various assessment and diagnostic tests used in clinical practice. This paper delves into one such diagnostic tool, the Prostate-Specific Antigen (PSA) test, exploring its application, significance, testing procedure, data collection, reliability, validity, and associated considerations.NURS 6512 Week 3
Description of the PSA Test
Prostate-Specific Antigen, commonly referred to as PSA, is a protein naturally present in the semen of men. It is produced by the prostate gland and is released in minimal amounts into the bloodstream under normal circumstances. However, conditions such as infection, cancer, or an enlarged prostate can lead to an abnormal elevation of PSA levels in the bloodstream (Fletcher, 2019). The National Cancer Institute (NCI) (2021) recommends that men aged 40 to 45 years at high risk and those aged 50 years at moderate risk undergo PSA testing for prostate cancer screening. The American Urological Association (AUA) suggests prostate screening for men aged 50 to 54 with an average risk of prostate cancer. Nevertheless, those with a high risk profile should engage in a discussion with their healthcare provider to make an informed decision regarding the necessity of the PSA test. The AUA also recommends that men aged 55 to 69 consider PSA screening if recommended by their physicians (Fletcher, 2019). Men aged 70 or older or those with a life expectancy of 10 to 15 years may not require PSA screening. Additional guidelines come from the American Academy of Family Physicians (AAFP) and the U.S. Preventive Services Task Force (UPSTF), which suggest that men aged 55 to 69 with a risk of prostate cancer may benefit from PSA screening (Tikkinen et al., 2018).NURS 6512 Week 3
Purpose of PSA Testing
The primary purpose of the PSA test is to identify elevated levels of PSA in the bloodstream, which can signify potential prostate issues, including cancer. PSA screening serves as an essential tool in the early detection and monitoring of prostate cancer, as higher PSA levels are often indicative of prostate abnormalities (Fletcher, 2019). This information allows healthcare providers to initiate timely interventions, establish appropriate treatment plans, and offer necessary support to patients. By assessing PSA levels, clinicians can contribute to the prevention and effective management of prostate cancer, ultimately improving patient outcomes.NURS 6512 Week 3
References:
Fletcher, S. W. (2019). Prostate-specific antigen (PSA) test for prostate cancer screening: Harms and benefits. UpToDate. https://www.uptodate.com/contents/prostate-specific-antigen-psa-test-for-prostate-cancer-screening-harms-and-benefits
National Cancer Institute (NCI). (2021). Prostate-specific antigen (PSA) test. https://www.cancer.gov/types/prostate/psa-fact-sheet
Tikkinen, K. A. O., Dahm, P., Lytvyn, L., Heen, A. F., Vernooij, R. W. M., Siemieniuk, R. A., … & Guyatt, G. H. (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: A clinical practice guideline. The BMJ, 362, k3581. https://www.bmj.com/content/362/bmj.k3581
